Carboxypeptidase D: A multitasking enzyme involved in Drosophila viability, development, behavior, and memory
by Sidyelyeva, Galyna, Ph.D., YESHIVA UNIVERSITY, 2010, 166 pages; 3407523

Abstract:

Carboxypeptidase D is an evolutionary conserved metallocarboxypeptidase, which is suggested to be involved in the production of biologically active molecules. In all species CPD has two active domains, a catalytically inactive third domain, a transmembrane domain and a cytosolic tail and is active towards C-terminal Lys and Arg. CPD displays broad pH optima and differential substrate preference. In contrast to mammalian CPD, Drosophila CPD undergoes alternative splicing and is represented by two soluble (inactive 1A and active 1B) and four full length forms.

Drosophila CPD is encoded by the silver gene. Two naturally occurring mutants, svr1 and svr poi demonstrate altered cuticle coloration and a pointed wing shape. Another silver mutant svrPG33 is lethal at the early larval stage. svr1 has a missing Leu in the transthyretin-like subdomain in the second CP domain, which affects folding of the full length protein and renders the affected domain inactive. svrpoi has a ∼1 kb duplication of the gene, inserted in the middle of the second CP domain, thus introducing a stop codon and creating a truncated protein. Soluble CPD forms are not affected in silver mutants. The lethal svrPG33 mutant has a P-element insertion just upstream of the initiating ATG codon and no CPD forms are made.

To further understand the importance of various CPD forms and its individual domains, we created several transgenic CPD lines in the svr PG33 background. All CPD forms tested except the inactive IA soluble form could rescue the lethality to various degrees. Forms with altered third CP domain showed reduced viability, suggesting that the inactive third CP domain is important for survival. svr1, svrpoi, and transgenic CPD mutants with overexpressed active domains displayed altered phenotypes in behaviors involving neuropeptides, which are similar to each other. All mutants showed affected cold and ethanol sensitivity; svr mutants showed memory deficit. Overexpression of both active CP domains reduced the levels of adipokinetic hormone Lys/Arg-extended intermediates. To summarize, our findings suggest that both enzymatically active CP domains have redundant functions in the processing of neuropeptides, hormones and growth factors and the inactive third CP domain is important for Drosophila viability.

 
AdvisersLloyd D. Fricker; Nicholas E. Baker
SchoolYESHIVA UNIVERSITY
SourceDAI/B 71-05, p. , Jun 2010
Source TypeDissertation
SubjectsMolecular biology; Biochemistry
Publication Number3407523
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3407523
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.